CDC Data Reveals Cancer Surge Following COVID Vaccinations

Data from the U.S. Centers for Disease Control and Prevention (CDC) and analyzed by The Exposé revealed that cancer incidents surged following COVID-19 vaccination when compared to other inoculations.

The Exposé accessed data from the CDC Vaccine Adverse Event Reporting System (VAERS), finding that while there were only 70 cancer cases associated with influenza vaccines between January 1, 2021, and March 29, 2024, there were 4,539 cancer cases linked to the COVID-19 vaccines during that same period.

Among those between the ages of 6-17, there was only 1 cancer case from a flu shot, compared to 12 cancer cases following the COVID-19 inoculation.

People in their 30s who received a flu shot during this time also reported just one instance of cancer, although there were 141 recorded cancer cases among this demographic after they received a COVID vaccine.

Those between the ages of 65-79 had the greatest rates of cancer following both the flu and COVID-19 vaccines.

The analysis of CDC data follows a recent preprint study linking COVID-19 vaccines with rising cancer rates.

The study investigated death rates from neoplasms, or an abnormal growth of tissue characteristic of cancer.

According to the authors, there was a “rise in excess mortality from neoplasms reported as the underlying cause of death” beginning in 2021 and continued increasing through 2022. Prior to 2020, neoplasm deaths had a consistent trend.

2020 saw an increased mortality of 3.4%, 2021 with 9.2%, and 2022 with 16.4%.

Describing the surge in mortality, the authors wrote, “This indicates a break from the existing trend in which people with cancer were increasingly dying of another condition or reason.”

While deaths in 2020 could be attributed to the negative health effects of widespread lockdown, the deaths in 2021 and 2022 “could be adverse effects of the COVID-19 vaccines, which were rolled out from 2021 and prioritized for vulnerable groups such as those with cancer,” according to the study.